Equillium, Inc. Share Price & Technical Analysis
EQ · $2.21 (+7.28%)
Healthcare / Biotechnology
$2.21
+7.28%
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 for…
Price chart
Seasonality
May has 1 positive and 0 negative years (last 5 years shown)
15% return in May, 0% avg return in past 3 year May month.
42% return in 2026, 139% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | 29% | 11% | 0% | 15% | – | – | – | – | – | – | – | 42% |
| 25 | -14% | 33% | -50% | 0% | 0% | -25% | 33% | 325% | -18% | 0% | -36% | 67% | 316% |
| 24 | 0% | 213% | -8% | -35% | 0% | -53% | 14% | 38% | -27% | 13% | -11% | 0% | 142% |
| 23 | 0% | -10% | -22% | -25% | 0% | 33% | -12% | 0% | -12% | -29% | 20% | 17% | -41% |
| 22 | 3% | -3% | -14% | -25% | 0% | -20% | 5% | 23% | -19% | -17% | -11% | -35% | -113% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$136.57M
P/E ratio
—
52W high
$2.70
52W low
$0.27
Volume
2,71,795
Beta
1.67
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Equillium, Inc. share price today?
- Equillium, Inc. (EQ) last traded around $2.21 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does EQ have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for EQ. Download the app for real-time alerts.
- How can I analyze Equillium, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.